| 英文别名 |
L-Tryptophan,3-[1,1'-biphenyl]-4-yl-N-(3,5-dimethylbenzoyl)-N-methyl-D-alanyl-;(2S)-2-[[(2R)-2-[(3,5-dimethylbenzoyl)-methylamino]-3-(4-phenylphenyl)propanoyl]amino]-3-(1H-indol-3-yl)propanoic acid;IRL-2500;N-3-[1,1'-Biphenyl]-4-yl-N-(3,5-diMethylbenzoyl)-N-Methyl-D-alanyl-L-tryptophan;Tocris-1838;IRL 2500;HY-103460;AS-84219;DTXSID20415511;HMS3412J16;N-3-[1,1'-Biphenyl]-4-yl-N-(3,5-dimethylbenzoyl)-N-methyl-D-alanyl-L-tryptophan;L-Tryptophan,3-[1,1'-biphenyl]-4-yl-N-(3,5-Dimethylbenzoyl)-N-methyl-d-alanyl-;AKOS024456806;SCHEMBL7444422;SR-01000597543-1;Q27078113;BDBM50071433;169545-27-1;CS-0027938;GTPL3887;NCGC00025309-02;CID 5311192;IRL-2500 is known as an ETB antagonist.;(S)-2-{(R)-3-Biphenyl-4-yl-2-[(3,5-dimethyl-benzoyl)-methyl-amino]-propionylamino}-3-(1H-indol-3-yl)-propionic acid;((R)-3-([1,1'-Biphenyl]-4-yl)-2-(N,3,5-trimethylbenzamido)propanoyl)-L-tryptophan;NCGC00025309-01;J-010557;CHEMBL72410;HMS3676J16;IRL2500;(2S)-2-[(2R)-3-{[1,1'-BIPHENYL]-4-YL}-2-[1-(3,5-DIMETHYLPHENYL)-N-METHYLFORMAMIDO]PROPANAMIDO]-3-(1H-INDOL-3-YL)PROPANOIC ACID;(2~{S})-2-[[(2~{R})-2-[(3,5-dimethylphenyl)carbonyl-methyl-amino]-3-(4-phenylphenyl)propanoyl]amino]-3-(1~{H}-indol-3-yl)propanoic acid;SR-01000597543;N-3-[1,1'-BIPHENYL]-4-YL-N-(3,5-DIMETHYLBENZOYL)-N-METHYL-D-ALANYL-L-TRYPTOPHAN |